Allianz Straddles Two Worlds: Record Earnings Peak Meets a Bearish Analyst Wager

Allianz posts record Q1 operating profit of €4.5B, beating forecasts, but Barclays sees 10% downside to €350 amid overbought RSI of 82 and limited upside. Dividend yield above 4% and strong capital position support long-term view.

The Munich-based insurer has delivered its strongest quarterly performance on record, but one of Europe’s most influential investment banks is betting the stock has further to fall. Barclays has reaffirmed an "Underweight" rating on Allianz shares with a target of €350, implying a correction of roughly 10% from the current level around €391.

Analyst Ivan Bokhmat argues the property and casualty business underperformed some rivals in the first quarter, while market volatility weighed on the life insurance segment. Despite solid profits, he sees insufficient earnings momentum to support the current valuation. Barclays prefers Munich Re and AXA within the sector. Technically, the relative strength index sits at 82, signalling an overbought condition, and with the stock trading just under 1% shy of its 52-week high of €394.80, upside appears limited.

Operationally, however, the picture is far rosier. The operating result jumped 6.6% to €4.5 billion, surpassing analyst forecasts. Net profit reached €3.8 billion, boosted by the sale of Indian joint ventures; adjusting for that one-off, earnings still climbed 7%. The asset management arm was a standout, with Pimco and Allianz Global Investors attracting a combined €45.2 billion in net inflows.

Management is sticking to its full-year operating profit target of €17.4 billion. The €2.5 billion share buyback programme is rolling forward: €300 million worth of shares were retired in the first quarter, and by early May the total had risen to €750 million. The strong capital position is backed by a Solvency II ratio of 221%, offering a solid buffer against potential claims.

For income-oriented investors, the dividend remains a draw. After paying €17.10 per share for the prior year, the market expects another increase, pushing the current yield above 4%.

Allianz is also betting big on technology. The internal “Nemo” project now automates claims handling, with seven specialised programmes reviewing applications and flagging fraud before a human signs off. The group spends roughly €6.5 billion annually on technology, the highest outlay in the sector, and expects productivity gains of up to 30%. Goldman Sachs views artificial intelligence and autonomous driving as potential structural advantages for the company.

Not everything is smooth. The health and life insurance segment posted a profit decline. The credit insurance arm, Allianz Trade, faces headwinds as global insolvencies rose 6% in the latest period, with Germany seeing an 11% jump. That remains a risk factor to watch.

The analyst consensus still points to a median price target near €400, placing Barclays in a distinct minority. Whether the second-quarter earnings season provides the stress test that confirms the bearish thesis or proves the record first quarter was no fluke will be the next key data point for investors.